Show simple item record

Identifying Novel Biomarkers Ready for Evaluation in Low-Prevalence Populations for the Early Detection of Lower Gastrointestinal Cancers : A Systematic Review and Meta-Analysis

dc.contributor.authorDruce, Paige
dc.contributor.authorCalanzani, Natalia
dc.contributor.authorSnudden, Claudia
dc.contributor.authorMilley, Kristi
dc.contributor.authorBoscott, Rachel
dc.contributor.authorBehiyat, Dawnya
dc.contributor.authorMartinez-Gutierrez, Javiera
dc.contributor.authorSaji, Smiji
dc.contributor.authorOberoi, Jasmeen
dc.contributor.authorFunston, Garth
dc.contributor.authorMessenger, Mike
dc.contributor.authorWalter, Fiona M.
dc.contributor.authorEmery, Jon
dc.date.accessioned2023-10-20T23:09:58Z
dc.date.available2023-10-20T23:09:58Z
dc.date.issued2021-06-01
dc.identifier225747382
dc.identifierb075d0db-7ac5-4b83-9d99-240306c3e81f
dc.identifier85104895086
dc.identifier33907946
dc.identifier000644876600001
dc.identifier.citationDruce , P , Calanzani , N , Snudden , C , Milley , K , Boscott , R , Behiyat , D , Martinez-Gutierrez , J , Saji , S , Oberoi , J , Funston , G , Messenger , M , Walter , F M & Emery , J 2021 , ' Identifying Novel Biomarkers Ready for Evaluation in Low-Prevalence Populations for the Early Detection of Lower Gastrointestinal Cancers : A Systematic Review and Meta-Analysis ' , Advances in Therapy , vol. 38 , no. 6 , pp. 3032-3065 . https://doi.org/10.1007/s12325-021-01645-6en
dc.identifier.issn1865-8652
dc.identifier.otherRIS: urn:6521C2898E25D8069758140171EC5302
dc.identifier.otherRIS: Druce2021
dc.identifier.otherORCID: /0000-0002-5068-2543/work/126804476
dc.identifier.urihttp://aura-test.abdn.ac.uk/handle/2164/19856
dc.descriptionFunding This study was supported by the CanTest Collaborative (funded by Cancer Research UK C8640/A23385) of which Fiona M. Walter is Director, Jon Emery is an Associate Director, Mike Messenger is co-investigator, and Natalia Calanzani and Garth Funston are researchers. The funder of the study had no role in study design, data collection, data analysis, data interpretation, or writing of the report. Paige Druce, Kristi Milley and Jon Emery are supported by the Cancer Australia Primary Care Collaborative Cancer Clinical Trials Group (PC4). Mike Messenger is funded by the NIHR Leeds In Vitro Diagnostic Co-operative (UK). No Rapid Service Fee or Open Access fee was received by the journal for the publication of this article.en
dc.format.extent34
dc.format.extent1409650
dc.language.isoeng
dc.relation.ispartofAdvances in Therapyen
dc.subjectSDG 3 - Good Health and Well-beingen
dc.subjectBiomarkersen
dc.subjectClinical practiceen
dc.subjectColorectal canceren
dc.subjectEarly detectionen
dc.subjectLower gastrointestinal cancersen
dc.subjectPrimary careen
dc.subjectRC0254 Neoplasms. Tumors. Oncology (including Cancer)en
dc.subjectPharmacology (medical)en
dc.subjectBiochemistryen
dc.subjectOncologyen
dc.subjectCancer Research UKen
dc.subjectC8640/A23385en
dc.subjectSupplementary Informationen
dc.subject.lccRC0254en
dc.titleIdentifying Novel Biomarkers Ready for Evaluation in Low-Prevalence Populations for the Early Detection of Lower Gastrointestinal Cancers : A Systematic Review and Meta-Analysisen
dc.typeJournal articleen
dc.contributor.institutionUniversity of Aberdeen.Other Applied Health Sciencesen
dc.description.statusPeer revieweden
dc.identifier.doihttps://doi.org/10.1007/s12325-021-01645-6
dc.identifier.urlhttp://www.scopus.com/inward/record.url?scp=85104895086&partnerID=8YFLogxKen
dc.identifier.vol38en
dc.identifier.iss6en


Files in this item

Thumbnail
Name:
Shekhar_etal_TAC_Rising_Winter ...
Size:
1.341Mb
Format:
PDF
View/Open

This item appears in the following Collection(s)

Show simple item record